Inserm_EN
@Inserm_EN
Followers
666
Following
51
Media
233
Statuses
545
Dear followers, this twitter account will now be inactive. Thank you for joining us on @Inserm !
Joined October 2013
Dear followers, this twitter account will now be inactive. Thank you for joining us on @Inserm !
1
0
0
Genomic Variability 2018 @Inserm Cross-Cutting Program - Submission deadline for letters of intent: April 2, 2018 https://t.co/E2B5ag7iJy
0
1
2
While disadvantaged people use emergency departments more frequently than the most advantaged, the reasons for their visit are just as often legitimate. A finding of an @Inserm team interested in the reasons for this increased use by certain patients https://t.co/QmSaOeK5L7
0
0
2
#Diabetes : a defect in communication between two intracellular organelles - mitochondria and endoplasmic reticulum – seems to be involved in the onset of insulin resistance https://t.co/RxspBbHlKB
0
0
0
[Research for and with patients] Rare Disease Day 2018 is specifically aimed at increasing patient participation in research. A day which, more than ever, is central to the work carried out at Inserm. https://t.co/Hw9GAMsgNU
#ShowYourRare #RareDiseaseDay
0
0
1
Limiting muscle aging: a nematode opens up a new approach ! At first sight, the nematode C. elegans has very little in common with humans… nevertheless, a mechanism related to muscular #aging has just been identified thanks to this worm https://t.co/sA639Xc52X
0
0
1
[Meet our Researchers] Co-discoverer of the AIDS virus and pioneer in regulatory T cell research, David Klatzmann : a translational immunologist https://t.co/l4zn2ot9AC
0
0
0
XX vs XY: If women have one more X than men, an inactivation mechanism allows equal expression of genes of both sexes. But some genes might escape it: a clue to explain the female susceptibility to autoimmune diseases... https://t.co/SAlspsgiI3
0
0
0
0
0
0
International #EpilepsyDay - a feature from our magazine Science&Santé that covers what we know and what we want to know to better treat epilepsy https://t.co/4NJwhJcRiW
0
0
0
Dendrogenin A, a cholesterol derivative, led to autophagy in human cancer cells. A discovery that paves the way for new possibilities in the treatment of #cancers
https://t.co/AbuJqULx7H
#Toulouse
0
1
1
The study of endocrine disruptors is of great importance to health & environment. However, this research raises several challenges. Explore current scientific knowledge and research about #endocrinedisruptors
https://t.co/k8Vgb1aZFF
0
1
0
The primary cilium, a potential therapeutic target in the fight against the #fibrosis encountered in #obesity and certain muscle diseases such as #DuchenneMuscularDystrophy
https://t.co/PjRxovqkAF
0
0
1
Already known for being an intracellular mediator, the SRC protein actually plays a bigger role: it also controls the production of the exosomes that cancer cells excrete into their environment. A discovery which can lead to new therapeutic avenues!
0
1
1
With a conventional microscope, measuring anything less than 200 nanometers is impossible. But with simulated emission depletion (STED) #microscopy and Sophie Allart's work, this limit has been lowered to 23 nanometers! https://t.co/bhznNLZr9X
#innovation
1
2
2
Could the Biological Clock Be a Key Ally in the Fight Against Inflammatory Disease? https://t.co/PZWTKsqm7e
0
0
1
Immunizing against #pain is a novel idea to say the least, but @Inserm researchers show that it is far from being a utopia. They have indeed recently proven, in mice, that a vaccination can alleviate visceral pain. https://t.co/8uy3oZ1u0b
0
1
1
Gene therapy and genetic variability, global network and national plans: Yves Lévy presents the Inserm roadmap for 2018 https://t.co/P7MelJBQ5z
0
1
2